CORRESP Filing
Jade Biosciences, Inc.
Date: Dec. 23, 2025 · CIK: 0001798749 · Accession: 0001193125-25-330829
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-292369
Letter
Re: Jade Biosciences, Inc. Registration Statement on Form S-1 File No. 333-292369 Ladies and Gentlemen: In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the above-referenced Registration Statement on Form S-1 (the “Registration Statement”) of Jade Biosciences, Inc. (the “Company”). We respectfully request that the Registration Statement become effective as of 4:00 p.m. Eastern Time on December 30, 2025, or as soon as practicable thereafter. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Latham & Watkins LLP, by calling Matt Bush at (858) 523-3962. Thank you for your assistance in this matter.
Jade Biosciences, Inc. 221 Crescent Street, Building 23, Suite 105 Waltham, Massachusetts 02453 December 23, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549-6010 Attn: Mr. Jimmy McNamara
Very truly yours,
JADE BIOSCIENCES, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP Jade Biosciences, Inc. 221 Crescent Street, Building 23, Suite 105 Waltham, Massachusetts 02453 December 23, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549-6010 Attn: Mr. Jimmy McNamara Re: Jade Biosciences, Inc. Registration Statement on Form S-1 File No. 333-292369 Ladies and Gentlemen: In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the above-referenced Registration Statement on Form S-1 (the “Registration Statement”) of Jade Biosciences, Inc. (the “Company”). We respectfully request that the Registration Statement become effective as of 4:00 p.m. Eastern Time on December 30, 2025, or as soon as practicable thereafter. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Latham & Watkins LLP, by calling Matt Bush at (858) 523-3962. Thank you for your assistance in this matter. Very truly yours, JADE BIOSCIENCES, INC. By: /s/ Bradford Dahms Bradford Dahms Chief Financial Officer cc: Tom Frohlich, Jade Biosciences, Inc. Elizabeth Balta, Jade Biosciences, Inc. Cheston Larson, Latham & Watkins LLP Matthew T. Bush, Latham & Watkins LLP Anthony Gostanian, Latham & Watkins LLP